Implantable Bluetooth Pacemaker Streamlines Remote Monitoring
|
By HospiMedica International staff writers Posted on 24 Jan 2022 |

Image: The Alizea pacemaker with Bluetooth connectivity (Photo courtesy of MicroPort CRM)
A novel pacemaker that pairs to a home monitor provides timely automated alerts and patient triggered warnings when symptomatic.
The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.
Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.
“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”
“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.
Related Links:
MicroPort
The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.
Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.
“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”
“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.
Related Links:
MicroPort
Latest Critical Care News
- AI Stethoscope Spots Heart Valve Disease Earlier Than GPs
- Bioadhesive Patch Eliminates Cancer Cells That Remain After Brain Tumor Surgery
- Wearable Patch Provides Up-To-The-Minute Readouts of Medication Levels in Body
- New Spray-Mist Device Delivers Antibiotics Directly into Infected Tissue
- Living Implant Could End Daily Insulin Injections
- Intelligent Camera System Continuously Monitors Premature Babies in NICU
- Intranasal Spray to Prevent Illnesses from Respiratory Viruses
- Gut Bacteria from Amphibians and Reptiles Show Complete Tumor Elimination
- High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
- AI Risk Prediction Tool Improves Treatment of Cancer Patients after Heart Attack
- Glowing Bacterial Sensors Could Improve Detection of Gut Illness
- Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment

- New Nanomaterial Kills Cancer Cells While Sparring Healthy Tissues
- AI Model Accurately Predicts Neurological Recovery After Cardiac Arrest
- Battery-Free Nano-Sensors Pave Way for Next-Generation Wearables
- Imaging Technology Detects Early Signs of Cardiovascular Risk Through Skin
Channels
Artificial Intelligence
view channelSurgical Techniques
view channel
Neural Device Regrows Surrounding Skull After Brain Implantation
Placing electronic implants on the brain typically requires removing a portion of the skull, creating challenges for long-term access and safe closure. Current methods often involve temporarily replacing... Read more
Surgical Innovation Cuts Ovarian Cancer Risk by 80%
Ovarian cancer remains the deadliest gynecological cancer, largely because there is no reliable screening test, and most cases are diagnosed at advanced stages. Thousands of patients die each year as treatment... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
Mindray North America and Medtronic have expanded their strategic partnership to bring integrated patient monitoring solutions to ambulatory surgery centers across the United States. The collaboration... Read more
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more







